TNF and discoid lupus erythematosus: Although the management of CLE by anti-TNF-α drugs is not yet well-defined, though different studies have tested their effectiveness in the most severe forms, Danielle et al. presented one case in whom the fully human monoclonal anti-TNF-α antibody adalimumab aggravated a persistent DLE [56].